NCT05890612
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- Pfizer Korea Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.
NCT05890612
NCT07146568
NCT05847894
NCT06898333
NCT07285122
NCT07484490
NCT07011810
NCT07619599
NCT07201051
NCT03578185